Fundraising FoxCure Pharmaceutical
Oxnard, US · California corporation
Find your way into Cure Pharmaceutical
Sign up to see every warm intro you have to Cure Pharmaceutical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cure Pharmaceutical team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RD
Rob DavidsonChief Executive Officer
MU
Mark UdellChief Financial Officer
Board
WN
Wayne NasbyBoard director
IS
Ian SephtonBoard director
VB
Vic BranstetterBoard director
EM
Ed MaliskiBoard director
Reported raises · per SEC filings
Form D private placements$8.7M disclosed across 5 rounds · 2011–2015
▶$6MraisedOct 2016 · 42 investors · PharmaceuticalsRule 506(b)
▶$6MraisedOct 2016 · 42 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Edward MaliskiDirector
- Rob DavidsonExecutive Officer, Director
- Wayne NasbyDirector
- Ian SephtonDirector
- Vic BranstetterDirector
- Mark UdellExecutive Officer
- Offering amount
- $6M
- Amount sold
- $6M
- Sales commissions
- $253.3K
- Placement agents
- Colorado Financial Service Corp.
- First sale
- Nov 2015
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$2MraisedOct 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$2MraisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Vic BranstetterDirector
- Ed MaliskiDirector
- Rob DavidsonExecutive Officer, Director
- Ian SephtonDirector
- Wayne NasbyDirector
- Mark UdellExecutive Officer
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Jul 2011
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$323.2KraisedOct 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$323.2KraisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ian SephtonDirector
- Wayne NasbyDirector
- Vic BranstetterDirector
- Rob DavidsonExecutive Officer, Director
- Mark UdellExecutive Officer
- Ed MaliskiDirector
- Offering amount
- $323.2K
- Amount sold
- $323.2K
- First sale
- Dec 2015
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$250KraisedOct 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$250KraisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ed MaliskiDirector
- Wayne NasbyDirector
- Vic BranstetterDirector
- Mark UdellExecutive Officer
- Rob DavidsonExecutive Officer, Director
- Ian SephtonDirector
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Jul 2015
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$80KraisedOct 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$80KraisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Wayne NasbyDirector
- Rob DavidsonExecutive Officer, Director
- Ian SephtonDirector
- Vic BranstetterDirector
- Mark UdellExecutive Officer
- Ed MaliskiDirector
- Offering amount
- $80K
- Amount sold
- $80K
- First sale
- Jun 2015
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cure Pharmaceutical raised?
- Cure Pharmaceutical has disclosed $8.7M raised across 5 rounds.
- Where is Cure Pharmaceutical headquartered?
- Cure Pharmaceutical is headquartered in Oxnard, US.